Immatics NV (IMTX)
10.08
-0.20
(-1.95%)
USD |
NASDAQ |
Dec 09, 16:00
10.32
+0.24
(+2.38%)
Pre-Market: 07:59
Immatics EPS Diluted (Quarterly): -0.4859 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CureVac NV | 1.414 |
| Evotec SE | -0.1417 |
| InflaRx NV | -0.2115 |
| BioNTech SE | -0.1395 |
| Anbio Biotechnology | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.06M |
| Revenue (Quarterly) | 6.061M |
| Total Expenses (Quarterly) | 65.13M |
| Enterprise Value | 738.37M |
| Profit Margin (Quarterly) | -974.4% |
| Earnings Yield | -10.85% |
| Normalized Earnings Yield | -11.79 |